UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results

Leukemia, 2017-11, Vol.31 (11), p.2529-2531

2017

Volltextzugriff (PDF)

Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients

Gynecologic oncology, 2019-05, Vol.153 (2), p.304-311

2019

Volltextzugriff (PDF)

Use of cytological samples of metastatic melanoma for ancillary studies

Cytopathology (Oxford), 2017-06, Vol.28 (3), p.221-227

2017

Volltextzugriff (PDF)

Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy

Annals of oncology, 2010-06, Vol.21 (6), p.1179-1188

2010

Volltextzugriff (PDF)

Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS

Current oncology (Toronto), 2012-06, Vol.19 (Suppl 1), p.S33-44

2012

Volltextzugriff (PDF)

Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer

Annals of oncology, 2015-07, Vol.26 (7), p.1415-1421

2015

Volltextzugriff (PDF)

Neoadjuvant erlotinib and surgical resection of a stage iiia papillary adenocarcinoma of the lung with an L861Q activating EGFR mutation

Current oncology (Toronto), 2012-06, Vol.19 (3), p.e222-226

2012

Volltextzugriff (PDF)

Benefits, issues, and recommendations for personalized medicine in oncology in Canada

Current oncology (Toronto), 2013-10, Vol.20 (5), p.e475-483

2013

Volltextzugriff (PDF)

Phase II study of PX-866 in recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-09, Vol.17 (9), p.1270-1274

2015

Volltextzugriff (PDF)

Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer

Current oncology (Toronto), 2011-08, Vol.18 (4), p.e180-184

2011

Volltextzugriff (PDF)

EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer

Current oncology (Toronto), 2012-04, Vol.19 (2), p.e67-74

2012

Volltextzugriff (PDF)

A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)

British journal of cancer, 2013-08, Vol.109 (4), p.943-949

2013

Volltextzugriff (PDF)

Immunoglobulin and T-cell receptor gene rearrangement in Castleman's disease: molecular genetic analysis

Histopathology, 2006-02, Vol.48 (3), p.233-238

2006

Volltextzugriff (PDF)

Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)

Gynecologic oncology, 2017-02, Vol.144 (2), p.250-255

2017

Volltextzugriff (PDF)

Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma

British journal of cancer, 2010-10, Vol.103 (9), p.1432-1442

2010

Volltextzugriff (PDF)

Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-04, Vol.30 (4), p.254-261

2018

Volltextzugriff (PDF)

Evidence-based best practices for EGFR T790M testing in lung cancer in Canada

Current oncology (Toronto), 2018-04, Vol.25 (2), p.163-169

2018

Volltextzugriff (PDF)

The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada

Current oncology (Toronto), 2019-12, Vol.26 (6), p.353-360

2019

Volltextzugriff (PDF)

Standardizing biomarker testing for Canadian patients with advanced lung cancer

Current oncology (Toronto), 2018-02, Vol.25 (1), p.73-82

2018

Volltextzugriff (PDF)

A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer

European journal of cancer (1990), 2014-07, Vol.50 (11), p.1909-1915

2014

Volltextzugriff (PDF)

Management of EGFR- mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspective

Current oncology (Toronto), 2017-04, Vol.24 (2), p.111-119

2017

Volltextzugriff (PDF)

Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario

Current oncology (Toronto), 2017-04, Vol.24 (2), p.103-110

2017

Volltextzugriff (PDF)

OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharing

Current oncology (Toronto), 2019-10, Vol.26 (5), p.e618-623

2019

Volltextzugriff (PDF)

Clinical utility of multigene profiling assays in early-stage breast cancer

Current oncology (Toronto), 2017-10, Vol.24 (5), p.e403-422

2017

Volltextzugriff (PDF)

Genomic Profiling and Matched Therapy for Recurrent or Metastatic Malignant Salivary Gland Tumors (MSGT): Preliminary Results

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.947-948

2016

Volltextzugriff (PDF)

1 – 25 von 443

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(403)
Mit Volltextzugriff
(407)

Publikationsform

Sprache

Englisch
(443)
Japanisch
(43)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(240)
Life Sciences & Biomedicine
(232)
Humans
(190)
Oncology
(136)
Female
(107)
Male
(103)
Middle Aged
(102)
Biological And Medical Sciences
(92)
Adult
(91)
Aged
(86)
Medical Sciences
(82)
Hematology
(61)
Tumors
(60)
Aged, 80 And Over
(52)
Mutation
(50)
Pathology
(48)
Prognosis
(40)
Hematologic And Hematopoietic Diseases
(35)
Treatment Outcome
(35)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(57)
Journal Of Clinical Oncology
(48)
Cancer Research
(16)
Current Oncology
(14)
Archives Of Pathology & Laboratory Medicine
(13)
Leukemia & Lymphoma
(13)
Oncogene
(13)
Cancer
(11)
The Journal Of Molecular Diagnostics : Jmd
(10)
Leukemia
(9)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results

Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients

Use of cytological samples of metastatic melanoma for ancillary studies

Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy

Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS

Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer

Neoadjuvant erlotinib and surgical resection of a stage iiia papillary adenocarcinoma of the lung with an L861Q activating EGFR mutation

Benefits, issues, and recommendations for personalized medicine in oncology in Canada

Phase II study of PX-866 in recurrent glioblastoma

Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer

EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer

A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)

Immunoglobulin and T-cell receptor gene rearrangement in Castleman's disease: molecular genetic analysis

Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)

Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma

Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy

Evidence-based best practices for EGFR T790M testing in lung cancer in Canada

The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada

Standardizing biomarker testing for Canadian patients with advanced lung cancer

A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer

Management of EGFR- mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspective

Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario

OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharing

Clinical utility of multigene profiling assays in early-stage breast cancer

Genomic Profiling and Matched Therapy for Recurrent or Metastatic Malignant Salivary Gland Tumors (MSGT): Preliminary Results

Suchergebnisse filtern